Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tatsuo Fuchigami is active.

Publication


Featured researches published by Tatsuo Fuchigami.


Developmental Medicine & Child Neurology | 2008

AUDITORY EVENT‐RELATED POTENTIALS AND REACTION TIME IN CHILDREN EVALUATION OF COGNITIVE DEVELOPMENT

Tatsuo Fuchigami; Osami Okubo; Yukihiko Fujita; Masahiko Okuni; Yukio Noguchi; Thoru Yamada

The authors studied age‐related correlations of auditory event‐related potentials (ERPs) using the conventional ‘oddball’ paradigm and reaction time in 175 normal subjects, aged between four and 21 years. From four years, the latencies of N100, N200 and P300 in ERP progressively shortened until about 16 to 17 years, after which they reached adult level, but with a slight tendency to prolongation towards 20 years; there was no trend for amplitude changes. The reaction time was more rapid than that of P300 latency. These findings indicate that the cognitive function of children improves rapidly until 16 to 17 years. A reduced difference between P300 latency and reaction time with age implies additional progress in motor skill. Combining P300 latency and reaction‐time studies may provide more detailed information for the evaluation of the development of cognitive function and motor skill.


Pediatrics International | 2011

Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children

Yasuji Inamo; Maki Hasegawa; Katsuya Saito; Rika Hayashi; Teruaki Ishikawa; Yayoi Yoshino; Koji Hashimoto; Tatsuo Fuchigami

Background:  Vitamin D is an immunomodulatory molecule related to innate immunity that may contribute to the increased occurrence of acute lower respiratory infection (ALRI) in children, one of the most common reasons for hospitalization and intensive care unit admission. In the present study, the association between vitamin D deficiency and the severity of respiratory infection was evaluated by determining serum concentrations of 25‐hydroxyvitamin D (25(OH)D) in a group of hospitalized children with ALRI.


Pediatric Emergency Care | 2012

Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature.

Ayumi Endo; Tatsuo Fuchigami; Maki Hasegawa; Koji Hashimoto; Yukihiko Fujita; Yasuji Inamo; Hideo Mugishima

Background Posterior reversible encephalopathy syndrome (PRES) is a recently described disorder with typical radiological findings of bilateral gray and white matter abnormalities in the posterior regions of the cerebral hemispheres and cerebellum. Its clinical symptoms include headache, decreased alertness, mental abnormalities such as confusion, diminished spontaneity of speech, and changed behavior ranging from drowsiness to stupor, seizures, vomiting, and abnormalities of visual perception such as cortical blindness. In this study, the clinical and radiological findings of 4 children with this syndrome due to a variety of conditions are reported. Methods The records of 4 children with a diagnosis of PRES were retrospectively analyzed. Results PRES is associated with a disorder of cerebrovascular autoregulation of multiple etiologies. Four patients with PRES who had primary diagnoses of severe aplastic anemia, nephritic syndrome, Henoch-Schönlein purpura, and acute poststreptococcal glomerulonephritis are presented. This syndrome has been described in numerous medical conditions, including hypertensive encephalopathy, eclampsia, and with the use of immunosuppressive drugs. Conclusions Early recognition of PRES as a complication during different diseases and therapies in childhood may facilitate precise diagnosis and appropriate treatment.


Brain & Development | 2010

A case of D-lactic acid encephalopathy associated with use of probiotics

Shun Munakata; Chikako Arakawa; Ryutaro Kohira; Yukihiko Fujita; Tatsuo Fuchigami; Hideo Mugishima

A five year old girl was admitted to the hospital for evaluation of intermittent ataxia. She had undergone serial resections of the small intestine after birth, resulting in short bowel syndrome. Lactomin was prescribed for watery diarrhea at twice the regular dose 2 weeks before the onset of neurologic symptoms. D-lactic acidosis was diagnosed on the basis of a plasma D-lactate level of 5.537 mmol/l. Lactomin was discontinued, and she was treated with sodium bicarbonate and oral antibiotics. The probiotics the patient had taken were likely the cause of D-lactic acidosis and should therefore be avoided in patients with short bowel syndrome.


International Archives of Allergy and Immunology | 2002

Intravenous Ulinastatin Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Patients

Yasuji Inamo; Takahiro Okubo; Mika Wada; Sachiko Fuchigami; Kouji Hashimoto; Tatsuo Fuchigami; Shigeru Takahashi; Shigemasa Sawada; Kensuke Harada

Background: More effective therapy is needed for the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The clinical efficacy of intravenous ulinastatin therapy was investigated in 3 Japanese pediatric patients with SJS or TEN. Methods: Ulinastatin was given to 1 pediatric SJS patient and 2 pediatric TEN patients within 7 days (patient 1; SJS), 6 days (patient 2; TEN), or 4 days (patient 3; TEN) after the onset of the skin rash. Ulinastatin was administered intravenously at a dose of 7,500 U/kg/day (maximum dose: 300,000 U/day). No corticosteroids were given. After the skin lesions resolved, the ulinastatin dose was reduced to between 2,500 and 5,000 U/kg/day as maintenance therapy and then the drug was withdrawn. Results: Erythema, fatigue, and fever improved within 12–36 h of starting the ulinastatin infusion, and the skin lesions resolved completely after 4–7 days of ulinastatin therapy. None of the patients had cutaneous or ocular sequelae. No patient developed secondary infection or relapse and ulinastatin therapy caused no side effects. Conclusion: Ulinastatin dramatically reduced the febrile period with no adverse effects and was very safe in this study. Ulinastatin appears to be a useful and effective therapy for controlling SJS and TEN without sequelae.


Pediatrics International | 2001

A study of mismatch negativity in newborns

Masaaki Tanaka; Osami Okubo; Tatsuo Fuchigami; Kensuke Harada

Abstract 
 Background : Although newborns are presumed to have cognitive ability, studies on the objective cognitive ability of neonates are making little progress.


Journal of Infection and Chemotherapy | 2013

A 4-year-old girl with clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection

Tatsuo Fuchigami; Kosei Goto; Maki Hasegawa; Katsuya Saito; Tomoko Kida; Koji Hashimoto; Yukihiko Fujita; Yasuji Inamo; Mitsutaka Kuzuya

Rotavirus is a common cause of severe gastroenteritis in children. It is known that rotavirus gastroenteritis may be accompanied by neurological manifestations, including encephalitis/encephalopathy and seizures. We report a case of a 4-year-old girl with clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection. She was admitted to our hospital because of reduced level of consciousness, seizures, diarrhea, and vomiting. Fecal rotavirus antigen testing was positive. Cell counts in the cerebrospinal fluid (CSF) were normal. She had a normal serum sodium level on admission. Brain computed tomography showed no cerebral edema. However, electroencephalography showed generalized high-voltage slow waves, and diffusion-weighted magnetic resonance imaging demonstrated a transient abnormality in the splenium of the corpus callosum. We diagnosed clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection. She recovered well and exhibited no neurological sequelae. Rotavirus RNA and antigen were not detected in the CSF, suggesting that the reversible splenial change was caused by indirect effects on the central nervous system subsequent to viral infection. Her normal serum sodium level indicates that this change can occur without hyponatremia.


Neurology | 1991

The effect of stimulus rate upon common peroneal, posterior tibial, and sural nerve somatosensory evoked potentials

Hiroaki Onishi; Thoru Yamada; Takanori Saito; Takumi Emori; Tatsuo Fuchigami; A. Hasegawa; T. Nagaoka; Mark A. Ross

We examined the effect of stimulus rate on somatosensory evoked potentials (SEPs) following stimulation of the common peroneal nerve (CPN) at the knee, and the posterior tibial nerve (PTN) and sural nerve (SN) at the ankle. We measured the amplitude of P40-N50 and N50-P60 in the PTN-SEP and corresponding amplitude of CPN-SEP and SN-SEP at the rate of 2.3, 3.4, 4.1, and 5.1 Hz. When the stimulation rate was increased from 2.3 to 5.1 Hz, the P40-N50 amplitude decreased by 50% for the CPN-SEP and 20% for the PTN-SEP. Also, the N50–P60 amplitude was reduced by 30% in the CPN-SEP and 20% in the PTN-SEP. In contrast, this change in stimulus rate produced no significant amplitude decline in the SN-SEP. Blocking the peroneal nerve with lidocaine just distal to the stimulating electrodes eliminated the descending peroneal nerve volley and abolished the amplitude attenuation observed with the faster stimulus rate. The findings suggest that at higher rates of stimulation, the afferent volleys induced by the movements that follow mixed nerve stimulation interfere with the SEP produced by electrical activation of the sensory afferents. The interference is greater when the more proximal site of the mixed nerve is stimulated.


Pediatrics International | 1993

Assessment of body composition measured by bioelectrical impedance in children

Kyoko Iwata; Yoshiyuki Satou; Fujihikoi Wata; Mitsuhiko Hara; Sachiko Fuchigami; Hideo Kin; Tatsuo Fuchigami; Tomooo Kada; Kensuke Harada; Masahiko Ohkuni; Shigeo Ryou; Shunji Ohashi

Bioelectorical impedance methods have been found to be a valid and reliable way of estimating per cent body fat (%BF) in adults. We applied them to healthy children and compared them with conventional anthropometry methods.


Acta Paediatrica | 1996

A case of Guillain‐Barré syndrome accompanied by sympathetic overactivity and hypertensive encephalopathy

T Okada; Kazuo Hiyoshi; N Noto; Yukihiko Fujita; Tatsuo Fuchigami; Osami Okubo; Kensuke Harada

Hypertension has often been observed in patients with Guillain‐Barré syndrome, and various underlying mechanisms have been implicated. We report the case of a child with the Guillain‐Barré syndrome whose hypertension was associated with increases in both renin activity and circulating catecholamines. This case also appeared to be complicated by hypertensive encephalopathy. Following administration of intravenous regitine, a blood pressure change was observed and cardiac performance was assessed by two‐dimensional echocardiography. Results indicated that increased total peripheral resistance may have been responsible for the symptoms and the hypertension. The hypertension was effectively managed by nifedipine, captopril and prazosin without the need for β‐blockade.

Collaboration


Dive into the Tatsuo Fuchigami's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge